Presence and potent immunosuppressive role of interleukin-10 in malignant pleural effusion due to lung cancer

Cancer Letters

Volumn 136, Issue 1, 1999, Pages 27-32

  Yanagawa, Hiroaki ^a   Takeuchi, Eiji ^a   Suzuki, Yoshihiro ^a   Ohmoto, Yasukazu ^a   Bando, Hiroyasu ^b   Sone, Saburo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b National Hospital Organization   (Japan)

Author keywords

Interleukin 10; Local immune response; Lung cancer; Pleural effusion; Pleural macrophages

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LUNG CANCER; MACROPHAGE; MALE; PLEURA EFFUSION; PLEURISY; PRIORITY JOURNAL;

AGED; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-1; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; LUNG NEOPLASMS; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033063099     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00299-7     Document Type: Article

References (30)

1. Romagnani S. Human Th1 and Th2 subsets: doubt no more. Immunol. Today. 12:1991;256-257.
2. Paul W.E., Seder P.A. Lymphocyte responses and cytokines. Cell. 76:1994;241-251.
3. Lucey D.R., Clerici M., Shearer G.M. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory disorders. Clin. Microbiol. Rev. 9:1996;532-562.
4. De Waar-Malefyt R., Yssel H., Roncarolo M.G., Spits H., De Vries J. Interleukin-10. Curr. Opin. Immunol. 4:1992;314-320.
5. Nabioullin R., Sone S., Mizuno K., Yano S., Nishioka Y., Haku T., Ogura T. IL-10 is a potent inhibitor of tumor cytotoxicity by human monocytes and alveolar macrophages. J. Leukocyte Biol. 55:1994;437-442.
6. Fiorentino D.F., Bond M.W., Mosmann T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:1989;2081-2095.
7. Buelens C., Verhasselt V., De Groote D., Thielemans K., Goldman M., Willems F. Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur. J. Immunol. 27:1997;756-762.
8. Fidler I.J. Macrophages and metastasis-a biological approach to cancer therapy: presidential address. Cancer Res. 45:1985;4714-4726.
9. Sone S. Role of alveolar macrophages in pulmonary neoplasias. Biochim. Biophys. Acta. 823:1986;227-245.
10. Antony V.B., Sahn S.A., Mossman B., Gaila D.B., Kalica A. Pleural cell biology in health and disease: NHLBI workshop summary. Am. Rev. Respir. Dis. 145:1992;1236-1239.
11. Gjomarkaj M., Pace E., Melis M., Spatofora M., Toews G.B. Mononuclear cells in exudative malignant pleural effusions. Characterization of pleural phagocytic cells. Chest. 106:1994;1042-1049.
12. Colotta F., Peri G., Villa A., Mantovani A. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage. J. Immunol. 132:1984;936-944.
13. Yanagawa H., Sone S., Nii A., Fukuta K., Nakanishi M., Maeda K., Honda M., Ogura T. Lymphokine-activated killer induction and its regulation by macrophages in malignant pleural effusion. Jpn. J. Cancer Res. 80:1989;1220-1227.
14. Yanagawa H., Yano S., Haku T., Ohmoto Y., Sone S. Interleukin-1 receptor antagonist in pleural effusion due to inflammatory and malignant lung disease. Eur. Respir. J. 9:1996;1211-1216.
15. Yanagawa H., Sone S., Sugihara K., Tanaka K., Ogura T. Interleukin-4 downregulates interleukin-6 production by human alveolar macrophages at protein and mRNA levels. Microbiol. Immunol. 35:1991;879-893.
16. Sone S., Yanagawa H., Nishioka Y., Orino E., Bhaskaran G., Nii A., Mizuno K., Heike Y., Ogushi F., Ogura T. Interleukin-4 as a potent down-regulator for human alveolar macrophages capable of producing tumor necrosis factor-α and interleukin-1. Eur. Respir. J. 5:1992;174-181.
17. Sone S., Orino E., Mizuno K., Yano S., Nishioka Y., Haku T., Ogura T. Production of interleukin-1 and its receptor antagonist is regulated differently by IFN-γ and IL-4 in human monocytes and alveolar macrophages. Eur. Respir. J. 7:1994;657-663.
18. Yanagawa H., Sone S., Haku T., Mizuno K., Yano S., Ohmoto Y., Ogura T. Contrasting effect of interleukin-13 on interleukin-1 receptor antagonist and proinflammatory cytokine production by human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 12:1995;71-76.
19. Barnes P.F., Lu S., Abrams J.S., Wang E., Yamamura M., Modlin R.L. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 61:1993;3482-3489.
20. Gotlieb W.H., Abrams J.S., Watson J.M., Velu T.J., Berek J.S., Martinez-Maza O. Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers. Cytokine. 4:1992;385-390.
21. Venetsanakos E., Beckman I., Bradley J., Skinner J.M. High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours. Br. J. Cancer. 75:1997;1826-1830.
22. Smith D.R., Kunkel S.L., Burdick M.D., Wilke C.A., Orringer M.B., Whyte R.I., Strieter R.M. Production of interleukin-10 by human bronchogenic carcinoma. Am. J. Pathol. 145:1994;18-25.
23. Huang M., Wang J., Lee P., Sharma S., Mao J.T., Meissner H., Uyemura K., Modlin R., Wollman J., Dubinett S.M. Human non-small cell lung cancer cell express a type 2 cytokine pattern. Cancer Res. 55:1995;3847-3853.
24. Huang M., Stolina M., Sharma S., Mao J.T., Zhu L., Miller P.W., Wollman J., Herschman H., Dubinett S.M. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res. 58:1998;1208-1216.
25. Chen Y.M., Yang W.K., Whang-Peng J., Kuo B.I.T., Perng R.P. Elevation of interleukin-10 levels in malignant pleural effusion. Chest. 110:1996;433-436.
26. Hart P.H., Vitti G.F., Burgess D.R., Whitty G.A., Piccoli D.S., Hamilton J.A. Potential antiinflammatory effects of interleukin 4 suppression of human monocyte tumor necrosis factor α, interleukin 1, and prostaglandin E2. Proc. Natl. Acad. Sci. USA. 8E:1989;3803-3807.
27. Hart P.H., Jones C.A., Finlay-Jones J.J. Monocytes cultured in cytokine-defined environments differ from freshly isolated monocytes in their responses to IL-4 and IL-10. J. Leukocyte Biol. 5:1995;909-918.
28. Carson W.E., Lindemann M.J., Baiocchi R., Linett M., Tan J.C., Chou C.C., Narula S., Caligiuri M.A. The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood. 1995;3577-3585.
29. Zheng L.M., Ojcius D.M., Garaud F., Roth C., Maxwell E., Li Z., Rong H., Chen J., Wang X.Y., Catino J.J., King I. Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism. J. Exp. Med. 184:1996;579-584.
30. Huang S., Xie K., Bucana C., Ullrich S.E., Bar-Eli M. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis. Clin. Cancer Res. 2:1996;1969-1979.